¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"intermediate cell mass"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® nerve cell ÇÑ±Û ½Å°æ¼¼Æ÷
¼³¸í   
  ½Å°æ¼¼Æ÷´Â ¿Ã¹Ù¸¥ ½Å°æÀü´ÞÀ» À§ÇÑ °¢ ºÎºÐº°·Î ³ª´µ¾îÁ® ÀÖ´Ù. ½Å°æ¼¼Æ÷¿¡¼­´Â ÀüÇØÁ®¿À´Â ÀÚ±ØÀ» Àü±âÀûÀΠ½ÅÈ£·Î ¹Ù²î¾î º¸³»°Å³ª ¹Þ°Ô µÈ´Ù. ÀÌ·± Àü±âÀûÀΠÇö»óÀº °¢ ½Å°æ¼¼Æ÷³»¿¡ Á¸ÀçÇϴ °¢ ÀÌ¿Âä³Î(ion channel: ionÀ̶õ ³ªÆ®·ý, Ä®·ý µîÀ» ÁöĪÇϴ ¸»µé·Î½á, À̵éÀÌ ¼¼Æ÷¸·¿¡ ÀÇÇØ ³ª´µ¾îÁú ¶§ »ý±â´Â Àü¾ÐÂ÷°¡ Àü±âÀû ÀÚ±ØÀ» ÀÏÀ¸Å°°í À¯ÁöÇϴµ¥ °áÁ¤ÀûÀΠ¿ªÇÒÀ» ÇÑ´Ù)µéÀÇ ÀÛ¿ë¿¡ ÀÇÇØ ÀÌ·ç¾îÁö°Ô µÈ´Ù.
¿µ¹® glia cell ÇÑ±Û ¾Æ±³¼¼Æ÷
¼³¸í   
  ½Å°æ¼¼Æ÷ »çÀÌ¿¡¼­ ±×¹°±¸Á¶¸¦ ÀÌ·ç¸ç À̸¦ ÁöÁöÇϴ Á¶Á÷. ½Å°æ¾Æ±³¼¼Æ÷´Â ½Å°æ¸ð¼¼Æ÷¿Í °¥¶óÁø ¾Æ±³¸ð¼¼Æ÷°¡ ´Ù½Ã ¿©·¯ ÇüÅ·ΠºÐÈ­-¼ºÀåÇÑ °ÍÀÌ´Ù. ³ú½ÇÀ̳ª Ã´¼öÁ߽ɰüÀÇ º®À» µ¤°í ¿øÁÖ»ó ¶Ç´Â ÀÔ¹æÇüÀ̸ç, Ãʱ⿡´Â À¯¸®¸é¿¡ ¼¶¸ð°¡ ÀÖ´Ù. ´ëÇü¼¼Æ÷´Â º°³ú½Ç¸·¼¼Æ÷´Â ¾Æ±³¼¼Æ÷¶ó°í Çϸç, ½Å°æ¼¼Æ÷³ª ½Å°æ¼¶À¯ »çÀÌ¿¡ »êÀçÇÑ´Ù. ±× ¿Ü¿¡ Èñ¼Òµ¹±â¾Æ±³¼¼Æ÷µµ Æ÷ÇԵȴÙ.
¿µ¹® reserve cell ÇÑ±Û ¿¹ºñ¼¼Æ÷
¼³¸í   
  ÀϹÝÀûÀ¸·Î »óÇÇÁ¶Á÷¿¡¼­ À̹̠ÀÖ´ø »óÇǼ¼Æ÷°¡ ¼Õ»óÀ» ¹Þ¾Æ »ç¸êÇϸ頸ŲãÁö´Â ±× ¹Ø¿¡ Àִ ¹ÌºÐÈ­¼¼Æ÷ ¿¹¸¦ µé¸é, ±â°üÁö ³»Ç¥¸éÀ» µ¤´Â ÁßÃþ ¿øÁÖ »óÇÇÀÇ ±âÀú¿¡ Àִ ÀÛÀº ¹ÌºÐÈ­ »óÇÇ ¼¼Æ÷.
¿µ¹® stem cell ÇÑ±Û Áٱ⼼Æ÷, °£¼¼Æ÷
¼³¸í   
  Àڱ⠺¹Á¦¸¦ ÇÏ¿© ÀÚ½ÅÀ» Á¸¼Ó½ÃŰ¸é¼­ ÇÑÆíÀ¸·Î´Â Áõ½Ä°ú ºÐÈ­¸¦ ÇÏ¿© »õ·Î¿î ¼¼Æ÷¸¦ Çü¼ºÇϴ ¼¼Æ÷·Î¼­ Á¶Ç÷Áٱ⼼Æ÷°¡ ´ëÇ¥ÀûÀÌ´Ù. Á¶Ç÷Áٱ⼼Æ÷´Â °ñ¼ö¿¡ Àִ ¼¼Æ÷·Î¼­ ¸ðµç Ç÷±¸¼¼Æ÷°¡ ¿©±â¿¡¼­ ºÐÈ­µÇ¾î ¹ß»ýÇÑ´Ù.
¿µ¹® renal cell carcinoma ÇÑ±Û ÄáÆÏ¼¼Æ÷¾ÏÁ¾
¼³¸í   
  ÄáÆÏ¿¡ »ý±ä ¿ø½ÃÄáÆÏÁ¶Á÷¿¡¼­ ¹ß»ýÇÑ ¾Ï. ÁַΠ¿ø½Ã¼¼´¢°üÁ¶Á÷¿¡¼­ ¹ß»ýÇÑ´Ù. ´ëÇ¥ÀûÀΠ¼¼Æ÷Á¶Á÷ÇüÀº ¿°»ö½Ã ¼¼Æ÷ÁúÀÌ ¸¼°Ô ºñ¾îº¸À̴ ¸¼Àº¼¼Æ÷¾ÏÁ¾ÀÌ´Ù. Ä¡·á´Â ¼ö¼ú°ú Ç×¾ÏÈ­Çпä¹ýÀ̸砾ÆÁÖ µå¹°Áö¸¸ ÀúÀý·Î ³´´Â °æ¿ìµµ Àִ °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intermediate reaction
    Áß°£¹ÝÀÀ
  • intermediate trait
    Áß°£¼ºÇâ(¼ÒÁú)
  • intermediate-acting insulin
    Áß°£ÀÛ¿ëÀν¶¸°
  • reactive intermediate
    ¹ÝÀÀÁß°£¹°Áú
  • replicative intermediate
    º¹Á¦Áß°£»ê¹°
  • atomic mass
    ¿øÀÚÁú·®
  • atomic mass unit
    ¿øÀÚÁú·®´ÜÀ§
  • achromatic mass
    ¹«»öµ¢ÀÌ, ºñ¿°»öµ¢ÀÌ
  • body mass index
    ½Åüºñ¸¸Áö¼ö, ½ÅüÁú·®Áö¼ö
  • cavitated mass
    ¼Óºóµ¢ÀÌ
  • charge to mass ratio
    ÀüÇÏ´ëÁú·®ºñ
  • effective mass
    À¯È¿Áú·®
  • electronic mass
    ÀüÀÚÁú·®
  • embryonic mass
    ¹è¾Æµ¢ÀÌ
  • echogenic mass
    ¸Þ¾Æ¸®¹ß»ýµ¢ÀÌ, ¿¡Äڹ߻ýÁ¾±«
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • basophilic cell
    È£¿°±â¼¼Æ÷
  • beta cell
    º£Å¸¼¼Æ÷
  • bipolar cell
    µÎ±Ø¼¼Æ÷
  • blood cell
    Ç÷¾×¼¼Æ÷, Ç÷±¸
  • ethmoidal cell
    ¹úÁý»À¹úÁý
  • eukaryotic cell
    ÁøÇÙ¼¼Æ÷
  • goblet cell
    ¼úÀܼ¼Æ÷
  • hair cell
    Åм¼Æ÷
  • inflammatory cell
    ¿°Áõ¼¼Æ÷
  • killer cell
    »ìÇØ¼¼Æ÷
  • Kupffer's cell
    º°Å«Æ÷½Ä¼¼Æ÷, ÄíÆÛ¼¼Æ÷
  • mast cell
    ºñ¸¸¼¼Æ÷
  • mesenchymal cell
    Áß°£¿±¼¼Æ÷
  • mesothelial cell
    ÁßÇǼ¼Æ÷
  • mother cell
    ¸ð¼¼Æ÷, ¾î¹Ì¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intermediate reaction
    Áß°£¹ÝÀÀ
  • intermediate spermatogonium
    Áß°£Á¤Á¶¼¼Æ÷
  • intermediate variable
    Áß°£º¯¼ö
  • intermediate density lipoprotein
    Á߹еµÁöÁú´Ü¹é
  • intermediate field magnetic resonance scanner
    ÁßµîÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • reactive intermediate
    ¹ÝÀÀÁß°£¹°Áú
  • replicative intermediate
    º¹Á¦Áß°£»ê¹°
  • posterior intermediate sulcus
    µÚÁß°£°í¶û
  • achromatic mass
    ¹«»öµ¢ÀÌ
  • atomic mass
    ¿øÀÚÁú·®
  • atomic mass unit
    ¿øÀÚÁú·®´ÜÀ§
  • mass action
    Áú·®ÀÛ¿ë
  • mass radiography apparatus
    Áý´Ü¹æ»ç¼±ÃÔ¿µÀåÄ¡, Áý´Ü°ËÁø¿¢½º¼±ÀåÄ¡
  • blanket mass treatment
    Àü¿øÄ¡·á
  • body mass index
    ½Åüºñ¸¸Áö¼ö, ½ÅüÁú·®Áö¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • posterior intermediate sulcus
    µÚÁß°£°í¶û
  • reactive intermediate
    ¹ÝÀÀ¼º Áß°£¹°Áú.
  • NK cell [=natural killer cell]
    ÀÚ¿¬»ì»ó¼¼Æ÷
  • alpha cell glucagon cell
    ¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
  • quiescent cell, Q cell
    Á¤Áö¼¼Æ÷
  • A cell
    A ¼¼Æ÷
  • B cell
    B¼¼Æ÷(~ á¬øà)
  • B cell
    B ¼¼Æ÷
  • B cell
    B ¼¼Æ÷.
  • B cell antigen
    B ¼¼Æ÷Ç׿ø
  • B cell differentiation factor (BCDF)
    B¼¼Æ÷ ºÐÈ­À¯¹ßÀÎÀÚ
  • B cell growth factor
    B ¼¼Æ÷¼ºÀåÀÎÀÚ
  • B cell growth factor (BCGF)
    B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
  • B cell hybridoma
    B¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
  • B cell lymphoma
    B¼¼Æ÷¸²ÇÁÁ¾
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dorsal mass
    µîÂʵ¢ÀÌ
  • echogenic mass
    ¿¡ÄÚ ¹ß»ý Á¾±«
  • effective mass
    À¯È¿Áú·®.
  • electronic mass
    ÀüÀÚÁú·®.
  • embryonic mass
    ¹èÀÚµ¢ÀÌ
  • equivalent mass
    µî°¡Áú·®
  • gravitational mass
    Áß·ÂÁú·®(ñìÕôòõÕá).
  • inertial mass
    °ü¼ºÁú·®(αàõòõåÖ).
  • infection, mass
    Áý´Ü°¨¿°
  • lateral mass
    ¿ÜÃøµ¢ÀÌ, ¿ÜÃø±«(èâö°ÎÔ).
  • lateral mass
    °¡Âʵ¢ÀÌ
  • lateral mass of sacrum<³ª> pars lateralis ossis sacri
    (õ°ñÀÇ) ¿ÜÃø±« (èâö°ÎÔ).
  • law of conservation of mass
    Áú·®º¸Á¸(òõåÖÜÁðí)ÀÇ ¹ýÄ¢(ÛööÎ).
  • law of mass action
    Áú·®ÀÛ¿ë(òõåÖíÂéÄ) ¹ýÄ¢.
  • lean body mass =LBM
    ¸¶¸¥Ã¼Áß, Á¦Áö¹æÃ¼Áß(ð¶ò·Û¸ô÷ñì).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Intermediate branch
    Áß°£°¡Áö
    [¿¾ ¿ë¾î] Áß°£Áö
  • Intermediate hepatic veins
    Áß°£°£Á¤¸Æ
    [¿¾ ¿ë¾î] Áß°£Á¤¸Æ
  • Intermediate zone
    Áß°£±¸¿ª
    [¿¾ ¿ë¾î] Áß°£´ë
  • Intermediate line
    Áß°£´É¼±
    [¿¾ ¿ë¾î] Áß°£¼±
  • Intermediate lymph nodes
    Áß°£¸²ÇÁÀý
    [¿¾ ¿ë¾î] Áß°£ÀÓÆÄÀý
  • Intermediate cervical septum
    Áß°£¸ñ»çÀ̸·
    [¿¾ ¿ë¾î] Áß°£°æºÎÁß°Ý
  • Intermediate dorsal cutaneous nerve
    Áß°£¹ßµîÇǺνŰæ
    [¿¾ ¿ë¾î] ÁßÁ·¹èÇǽŰæ
  • Intermediate ventral nucleus
    Áß°£¹èÂÊÇÙ
    [¿¾ ¿ë¾î] Áß°£º¹ÃøÇÙ
  • Intermediate part
    Áß°£ºÎºÐ
    [¿¾ ¿ë¾î] Áß°£ºÎ
  • Intermediate part [Red part]
    Áß°£ºÎºÐ
    [¿¾ ¿ë¾î] Áß°£ºÎ
  • Intermediate supraclavicular nerves
    Áß°£ºøÀåÀ§½Å°æ
    [¿¾ ¿ë¾î] Áß°£¼â°ñ»ó½Å°æ
  • Intermediate body
    Áß°£¼Òü
    [¿¾ ¿ë¾î] Áß°£¼Òü
  • Intermediate ganglia
    Áß°£½Å°æÀý
    [¿¾ ¿ë¾î] Á߽ŰæÀý
  • Intermediate atrial branch
    Áß°£½É¹æ°¡Áö
    [¿¾ ¿ë¾î] Áß°£½É¹æÁö
  • Intermediate cuneiform bone
    Áß°£½û±â»À
    [¿¾ ¿ë¾î] Áß°£¼³»ó°ñ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • tegumental cell
    Ç¥ÇǼ¼Æ÷
  • vitelline cell
    ³­È²¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lean body mass
    Å»Áö¹æÃ¼Áß(÷­ò·Û®ô÷ñì)
  • mass absorption coefficient
    Áú·®Èí¼ö°è¼ö(òõÕáýåâ¥Ìõâ¦)
  • mass action
    Áú·®ÀÛ¿ë(òõÕáíÂéÄ)
  • mass-action ratio
    Áú·®ÀÛ¿ëÀ²(òõÕáíÂéÄëÒ)
  • mass balance equation
    Áú·®±ÕÇü¹æÁ¤½Ä(òõÕáгû¬Û°ïïãÒ)
  • mass chromatogram
    Áú·®(òõÕá) Å©·Î¸¶Åä±×·¥
  • mass fragmentography
    Áú·®(òõÕá) ÇÁ·¡±×¸àÅä±×·¡ÇÇ
  • mass number
    Áú·®¼ö(òõÕáâ¦)
  • mass spectrogram
    Áú·®ºÐ±¤µµ(òõÕáÝÂÎÃÓñ)
  • mass spectrograph
    Áú·®ºÐ±¤±â(òõÕáÝÂÎÃѦ)
  • mass spectrometer
    Áú·®ºÐ±¤°è(òõÕáÝÂÎÃͪ)
  • mass spectrum
    Áú·®(òõÕá) ½ºÆåÆ®·³
  • mass unit
    Áú·®´ÜÀ§(òõÕáÓ¤êÈ)
  • molar mass
    ¸ô Áú·®(òõÕá)
  • molecular mass
    ºÐÀÚÁú·®(ÝÂí­òõÕá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mobile mass radiography stand
    À̵¿Çü Áý´Ü¹æ»ç¼±ÃÔ¿µ´ë
  • polypoid mass
    Æú¸³¾çÁ¾±«
  • sonolucent mass
    ÃÊÀ½ÆÄÅõ°ú¼ºÁ¾±«
  • acinar cell
    Æ÷»ó¼¼Æ÷
  • air cell
    ÇԱ⵿
  • alveolar cell carcinoma
    ÆóÆ÷¼¼Æ÷¾ÏÁ¾
  • basal cell carcinoma
    ±âÀú¼¼Æ÷¾ÏÁ¾
  • blast cell
    ¸ð¼¼Æ÷
  • blood cell
    Ç÷±¸
  • cell
    ¼¼Æ÷, ¹úÁý, ºÀ¼Ò, °ÇÀüÁö
  • chromaffin cell
    Å©·Òģȭ¼¼Æ÷
  • clear cell
    Åõ¸í ¼¼Æ÷
  • columnar cell
    ¿øÁÖ¼¼Æ÷
  • cuboidal cell
    ÀԹ漼Æ÷
  • daughter cell
    µþ¼¼Æ÷, ³¶¼¼Æ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MMR mass miniature radiography; masseter muscle rigidity; maternal mortality rate; measles-mumps-rubella...
ACC accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst...
BCM B-cell maturation; birth control medication; blood-clotting mechanism effects; body cell mass; body ...
IC icteric, icterus; immune complex; immunoconjugate; immunocytochemistry; immunocytotoxicity; impedanc...
GC ganglion cell; gas chromatography; general circulation; general closure; general condition; generali...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ICFs Intermediate Care Facilities
IDL Intermediate Density Lipoprotein
IF Intermediate Filament
IRM Intermediate Restorative Material
IR Intermediate Risk
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • atomic mass
    ¿øÀÚ Áú·®
  • cavitated mass
    °øµ¿¼º Á¾±«
  • diffuse gingival mass
    ¹Ì¸¸¼º Ä¡Àº Á¾¾ç
  • echogenic mass
    ¿¡ÄÚ ¹ß»ý Á¾±«
  • effective mass
    À¯È¿ Áú·®
  • electronic mass
    ÀüÀÚ Áú·®
  • mass absorption coefficient
    Áú·® Èí¼ö °è¼ö
  • mass examination
    Áý´Ü °ËÁø, Áý´Ü °ËÁø °Ë»ç
  • mass increase
    ÀÀ¾î¸® Áõ°¡
  • mass lesion
    Á¾±«¼º º´º¯
  • mass miniature radiography
    Áý´Ü Ãà¼Ò ¹æ»ç¼± ÃÔ¿µ¼ú, Áý´Ü °£Á¢ ÃÔ¿µ¼ú
  • mass movement
    Áý´Ü ¿îµ¿
  • mass peristalsis
    Áý´Ü ¿¬µ¿, ´ë·® À̵¿¼º ¿¬µ¿
  • mass radiography apparatus
    Áý´Ü ¹æ»ç¼± ÃÔ¿µ ÀåÄ¡
  • mass spectrography
    Áú·® ºÐ±¤ °èÃø¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
para-sellar mass <radiology> Mnemonic: SATCHMO, S sphenoid sinus tumour, A aneurysm / adenoma of pituitary, T teratoid lesion, C craniopharyngioma, H hypothalamic glioma / histiocytoma, M meningioma / metastasis, O optic glioma less common lesions: germinoma, epidermoid, hamartoma, chordoma, arachnoid cyst
(12 Dec 1998)
mass <chemistry> The quantity of matter in an object.
(09 Jan 1998)
mass-action ratio The ratio of the product of all of the product concentrations divided by the product of all of the reactant concentrations of a particular reaction; when the reaction has been completed (i.e., t = &infin;), then this ratio is equal to the equilibrium constant.
(05 Mar 2000)
mass action theory That large areas of brain tissue function as a whole in learned or intelligent action.
(05 Mar 2000)
mass action transmission <epidemiology> Transmission of infection which occurs at a rate directly proportional to the number or density of both susceptibles and infecteds present.
Some authors reserve the name mass action for transmission processes of the form b X Y/N , which we associate with STD-type transmission, and describe transmission rates of the form b X Y , as pseudo-mass action ; the two are equivalent if the population size is unchanging.
(05 Dec 1998)
mass at base of tongue <radiology> Lingual thyroid, thyroglossal duct cyst, haemangioma, other neoplasm
(12 Dec 1998)
mass attenuation coefficient <physics> The mass attenuation coefficient, u/p, of a material for uncharged ionising particles is the quotient of DN/N by pdl, where DN/N is the fraction of particles that experience interactions in traversing a distance dl in a material of density p.
(16 Dec 1997)
mass behaviour Collective behaviour of an aggregate of individuals giving the appearance of unity of attitude, feeling, and motivation.
(12 Dec 1998)
mass burn facility A facility in which the pretreatment of MSW includes only inspection and simple separation to remove oversize, hazardous, or explosive materials. Large mass burn facilities have capacities of 3000 tons of MSW per day or more. Modular plants with capacities as low as 25 tons per day have been built. Mass burn technologies represent over 75% of all the MSW-to-energy facilities constructed in the United States to date. The major components of a mass burn facility include refuse receiving and handling, combustion and steam generation, flue gas cleaning, power generation, condenser cooling water, residue hauling, and storage.
(05 Dec 1998)
mass chest X-ray X-ray screening of large groups of persons for diseases of the lung and heart by means of radiography of the chest.
(12 Dec 1998)
mass defect <chemistry, radiobiology> Of a nucleus, the difference between the sum of the masses of the constituent nucleons and the mass of the nucleus.
(16 Dec 1997)
mass effect <neurology> Damage to the brain due the bulk of a tumour, the blockage of fluid or excess accumulation of fluid within the skull.
(16 Dec 1997)
mass energy absorption coefficient <physics> The mass energy absorption coefficient, uen/p of a material for uncharged ionising particles is the product of the mass energy transfer coefficient, utr/p and (1 - g) where g is the fraction of the energy of secondary charged particles that is lost to bremsstrahlung in the material.
(16 Dec 1997)
mass fragmentography A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds.
(12 Dec 1998)
mass hysteria Spontaneous, en masse development of identical physical and/or emotional symptoms among a group of individuals, as seen in a classroom of schoolchildren, a socially contagious frenzy of irrational behaviour in a group of people as a reaction to an event.
Synonym: epidemic hysteria.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • high Mass
    (Ä«Å縯) Àå¾öÇÑ ¹Ì»ç
  • mass
    µ¢¾î¸®;Áý´Ü;´Ù¼ö;´Ù·®(He is a ~ of bruises Àü½Å »óó Åõ¼ºÀÌ´Ù);ŹÝ;Áú·® in the ~ ÅëÆ²¾î;the (great) ~ of ...ÀÇ ´ëºÎºÐ;the ~es ´ëÁß
  • mass
    ¹Ì»ç(Ä«Å縯±³ÀÇ ¼ºÃ¼ ¼º»ç);¹Ì»ç°î High Mass (ºÐÇâ,ÁÖ¾ÇÀÌ ÀÖ´Â) ´ë¹Ì»ç
  • mass
    ÇÑ µ¢¾î¸®·Î ÇÏ´Ù(µÇ´Ù);ÁýÁß½ÃŰ´Ù(ÇÏ´Ù)
  • mass action
    Áú·® ÀÛ¿ë
  • mass behavior
    ´ëÁß Çൿ
  • mass circulation
    (´ë·® ¹ßÇàÇÏ´Â) ÀÏ¹Ý ´ëÁß ÀâÁö
  • mass communication
    ´ëÁß Àü´Þ;¸Å½ºÄ¿¹Â´ÏÄÉÀ̼Ç
  • mass defect
    Áú·® °á¼Õ
  • mass driver
    ¿ìÁÖ ±âÀç ¹ß»ç ÀåÄ¡
  • mass energy
    Áú·® ¿¡³ÊÁö
  • mass game
    Áý´Ü °æ±â
  • mass grave
    °øµ¿ ¹¦Áö (µ¿½Ã¿¡ ¸ÅÀåµÈ ¸¹Àº »ç¶÷µéÀÇ ¹¦Áö)
  • mass leave
    (Àεµ¿¡¼­ Ç×ÀÇÇϱâ À§ÇØ ¸¹Àº Á¾¾÷¿øÀÌ ÇÏ´Â) ÀÏÁ¦ ÈÞ°¡
  • mass man
    ´ëÁßÀû(Áý´Ü) Àΰ£ (´ëÁß »çȸ¸¦ ±¸¼ºÇÏ´Â °¡Á¤µÈ ÀüÇüÀû Àΰ£À¸·Î,°³¼ºÀÌ »ó½ÇµÊ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á